Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.2717
Nov 13 • 3:58 PM ET Dollar change-0.0036 Percentage change(-1.31%)
Aftermarket Close
0.2760
Aftermarket • 5:50 PM ET Dollar change+0.0043 Percentage change(1.58%)
Index
-
Market Cap
38.12M
Enterprise Value
53.91M
Income
-11.14M
Sales
109.53M
Book/sh
0.29
Cash/sh
0.07
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
151
IPO
Jul 01, 2010
P/E
-
Forward P/E
-
PEG
-
P/S
0.35
P/B
0.95
P/C
3.73
P/FCF
-
EV/EBITDA
-
EV/Sales
0.49
Quick Ratio
1.05
Current Ratio
2.16
Debt/Eq
0.65
LT Debt/Eq
0.24
Option/Short
No / Yes
EPS (ttm)
-0.08
EPS next Y
-0.01
EPS next Q
-0.03
EPS this Y
-183.33%
EPS next Y
60.00%
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
32.20% 20.22%
EPS Y/Y TTM
-132.84%
Sales Y/Y TTM
-14.27%
EPS Q/Q
-380.75%
Sales Q/Q
-34.96%
Insider Own
12.43%
Insider Trans
0.00%
Inst Own
56.95%
Inst Trans
-0.59%
ROA
-12.16%
ROE
-25.16%
ROIC
-22.41%
Gross Margin
59.39%
Oper. Margin
-9.58%
Profit Margin
-10.17%
SMA20
-4.96%
SMA50
-14.44%
SMA200
-38.75%
Trades
Shs Outstand
140.26M
Shs Float
122.86M
52W High
0.84 -67.65%
52W Low
0.27 0.56%
Volatility
8.91% 8.93%
ATR (14)
0.03
RSI (14)
37.99
Beta
-0.25
Rel Volume
0.11
Avg Volume
1.67M
Volume
181,748
Perf Week
-6.12%
Perf Month
-10.27%
Perf Quarter
-18.04%
Perf Half Y
-40.40%
Perf YTD
-65.34%
Perf Year
-58.83%
Perf 3Y
-76.78%
Perf 5Y
-75.30%
Perf 10Y
-96.18%
Prev Close
0.28
Price
0.27
Change %
-1.31%
Consensus
Strong Buy
Avg. Price Target
$1.03
Implied Upside
+279.1%
Analysts2incl. previous ratings
Rating Distribution2 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Dec 05, 2023Initiated
BBTIG Research
Buy$2+636.1%
Nov 15, 2018Reiterated
MMaxim Group
Buy$10 → $6+2,108.3%
Feb 14, 2018Reiterated
MMaxim Group
Buy$18 → $10+3,580.5%
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoSTX, Certex Spinal Fixation System, Axle Interspinous Fusion System, and Calix. The company was founded in 2006 and is headquartered in Belgrade, MT.
PresidentMr. Sean E. Browne
Chief Financial OfficerMr. Scott C. Neils
Chief Operations OfficerMr. Mark A. Schallenberger
Vice President of Human ResourcesMs. Catherine Lundy